CCIA
MGNX icon

Campbell & Co Investment Adviser’s MacroGenics MGNX Stock Holding History

Campbell & Co Investment Adviser’s Portfolio MGNX Stock Details MGNX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-17,915
Closed -$264K – 1238
2024
Q1 		$264K Sell
17,915
-75,090
-81% -$1.13M 0.02% 951
2023
Q4 		$895K Buy
+93,005
New +$643K 0.08% 433
2022
Q2 		– Sell
-29,955
Closed -$264K – 821
2022
Q1 		$264K Buy
+29,955
New +$331K 0.07% 521
2019
Q4 		– Sell
-27,035
Closed -$345K – 768
2019
Q3 		$345K Buy
+27,035
New +$389K 0.13% 320
2019
Q2 		– Sell
-18,122
Closed -$326K – 634
2019
Q1 		$326K Buy
+18,122
New +$313K 0.16% 247

Other funds holding MGNX

BG
Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
FLSM
Frazier Life Sciences Management Palo Alto, California $3.89B AUM 201.1% 1-Year Est. Return
WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Campbell & Co Investment Adviser's MGNX Position: Q2 2024 in Review

Campbell & Co Investment Adviser sold out of MacroGenics (MGNX) in Q2 2024, closing a stake of 17,915 shares — an estimated $264K sold.

Campbell & Co Investment Adviser first reported a position in MGNX in Q1 2019 and held it in 5 quarters. The position peaked at $895K in Q4 2023. 146 funds tracked by Wall St. Rank hold MGNX as of Q2 2024.

  • Campbell & Co Investment Adviser reported no remaining MacroGenics position as of Q2 2024 after selling out during the quarter.
  • Campbell & Co Investment Adviser sold 17,915 MacroGenics shares in Q2 2024, an estimated $264K.
  • Campbell & Co Investment Adviser first reported a position in MacroGenics in Q1 2019 and held it in 5 quarters.
  • Campbell & Co Investment Adviser's MacroGenics position peaked at $895K in Q4 2023.
  • 146 funds tracked by Wall St. Rank held MacroGenics as of Q2 2024.

Based on Campbell & Co Investment Adviser's 13F filing for Q2 2024, filed 13 Aug 2024.